Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Call for papers - Infectious disease and antibiotic resistance epidemiology

Guest Editors

Abdulrahman S. Bazaid, PhD, University of Hail, Saudi Arabia
Dennis Nurjadi, MD, University of Lübeck and University Medical Center of Schleswig-Holstein, Germany

Submission Status: Open   |   Submission Deadline: 19 September 2025

BMC Infectious Diseases invites submissions for a Collection on Infectious disease and antibiotic resistance epidemiology. This collection welcomes researches to contribute to the understanding of the dynamics of infectious diseases and the implications of antibiotic resistance. We aim to explore the mechanisms, trends, and impacts of antibiotic resistance, as well as effective strategies for surveillance and stewardship. By sharing insights and findings, we hope to inform public health initiatives and improve outcomes in the fight against resistant infections.

Meet the Guest Editors

Back to top

Abdulrahman S. Bazaid, PhD, University of Hail, Saudi Arabia

Dr Bazaid is an Associate Professor in medical microbiology and currently interested in Surveillance and emergence of antibiotic-resistant bacteria research (e.g., methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, carbapenemase-producing Enterobacterales, MDR Pseudomonas aeruginosa, carbapenem-resistant Acinetobacter baumannii). His reserch includes identifying active agents against multidrug-resistant organisms and discovering novel antibiotics from natural products.

Dennis Nurjadi, MD, University of Lübeck and University Medical Center of Schleswig-Holstein, Germany

Dr Nurjadi is a board-certified clinical microbiologist and professor at the University of Lübeck with extensive expertise in antimicrobial resistance (AMR) and bacterial genomics. As an expert in the field, his research focuses on unravelling the mechanisms and evolutionary pathways that drive the emergence and spread of AMR, with particular emphasis on challenges faced by low- and middle-income countries. Dr Nurjadi's work combines advanced genomic technologies with a deep understanding of global health dynamics, with the aim of translating scientific discoveries into actionable strategies to mitigate the impact of AMR on health systems. Dr Nurjadi is affiliated with the German Center for Infection Research (DZIF), contributing to projects that advance understanding and intervention in infectious diseases. Additionally, he is an active member of PACE-UP, the Pan ASEAN Coalition for Epidemic and Outbreak Preparedness, where he supports efforts to improve microbiological diagnostics and address antimicrobial resistance globally.

About the Collection

BMC Infectious Diseases welcomes submissions to our Collection Infectious disease and antibiotic resistance epidemiology. 

Infectious disease and antibiotic resistance epidemiology are critical areas of research that intersect to address the growing threat posed by antibiotic resistant pathogens. The rise of antibiotic resistance has emerged as a global health crisis, complicating the treatment of common infections and leading to increased morbidity and mortality. Understanding the epidemiological patterns of infectious diseases, alongside the mechanisms and trends of antibiotic resistance, is essential for developing effective public health strategies. This Collection aims to explore the dynamics of infectious diseases and the implications of antibiotic resistance, providing a platform for researchers to share their findings and insights.

Advancing our understanding of infectious disease and antibiotic resistance epidemiology is vital for informing public health policies and clinical practices. Recent developments in genomic sequencing and epidemiological surveillance have enhanced the ability to track resistance patterns and identify emerging threats. Furthermore, the implementation of antibiotic stewardship programs has shown promise in mitigating the impact of antibiotic resistance. Continued research in this area will enable the development of targeted interventions, enhance patient treatment, improve infection control measures, and ultimately reduce the burden of resistant infections on healthcare systems.

This Collection seeks to enhance our understanding on infectious disease and antibiotic resistance epidemiology. By fostering interdisciplinary collaboration, we can improve the capacity to combat antibiotic resistance and safeguard public health. Key topics of interest for submission include, but are not limited to:

  • Epidemiological surveillance of antibiotic resistance
  • Mechanisms of multidrug resistance (MDR)
  • Antibiotic stewardship practices and outcomes
  • Resistance patterns in healthcare-associated infections
  • Genotypic and phenotypic resistance profiling


All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.

Image credit: © Mykola Sosiukin / Getty Images / iStock

  1. Nocardia farcinica, a gram-positive filamentous bacterium, is predominantly found in individuals with compromised immune systems. Bacteremia caused by Nocardia farcinica is relatively rare.

    Authors: Haizhen Su, QianYing Zhu, Yi Zhang, Fei Xia, Mengchu Zhu, Lei Jiang and Qing Zhang
    Citation: BMC Infectious Diseases 2025 25:792
  2. Small genetic modules, such as toxin-antitoxin (TA) systems, play specific roles in persistence, antibiotic resistance, and virulence in pathogenic bacteria. Given the transmission of M. bovis to humans and the i...

    Authors: Maryam Shafipour, Abdolmajid Mohammadzadeh, Ezzat Allah Ghaemi, Pezhman Mahmoodi and Nader Mosavari
    Citation: BMC Infectious Diseases 2025 25:791
  3. The relentless evolution of K. pneumoniae ST307 into a “superbug” with dual resistance to last-line antibiotics and hospital disinfectants poses an existential threat to infection control. This study characterize...

    Authors: Rezvan Goodarzi, Sima Kazemi, Mohammad Hossein Nasershariati and Babak Asghari
    Citation: BMC Infectious Diseases 2025 25:790
  4. Salmonellosis in humans and animals poses significant public health concerns, leading to substantial economic losses and increased healthcare costs in both developed and developing countries. This study aimed ...

    Authors: Getachew Mengistu, Anwar Nuru, Baye Gelaw and Feleke Moges
    Citation: BMC Infectious Diseases 2025 25:771
  5. The coronavirus SARS-CoV-2 (COVID-19) experience has underscored the consequences of inequalities in health and access to health services across and within countries. Vulnerable population groups have been dis...

    Authors: Arnaud Iradukunda, Fentabil Getnet and Emmanuel Nene Odjidja
    Citation: BMC Infectious Diseases 2025 25:716
  6. Methicillin-resistant Staphylococcus aureus (MRSA) is a major pathogen causing ear infections. However, genomic epidemiology and determinants influencing transmission of ear infections associated MRSA (EIA-MRSA) ...

    Authors: Zhewei Sun, Jinhong Chen, Chunhong Liu, Yueru Tian, Fuqi Ai, Jiaying Du, Wangxiao Zhou, Wenjun Cao, Ming Guan and Baixing Ding
    Citation: BMC Infectious Diseases 2025 25:661
  7. Contaminated food with Shiga-toxin producing Escherichia coli (STEC) can cause diarrhea and severe diseases in consumers. This study aimed to assess the phenotypic and genotypic characteristics of virulence and a...

    Authors: Elyas Shahrivar, Ebrahim Rahimi and Faham Khamesipour
    Citation: BMC Infectious Diseases 2025 25:581
  8. Penicillin-resistant Streptococcus pneumoniae (PRSP), for which novel treatment medicines are required, has expanded extensively due to the overuse of antibiotics. This study aimed to detect the optimal ratio of ...

    Authors: Jiangbo Lv, Haofang Wan, Daojun Yu, Huifen Zhou, Wenba Wang and Haitong Wan
    Citation: BMC Infectious Diseases 2025 25:565
  9. MRSA represents a significant public health challenge, particularly in resource-constrained regions like Africa. A critical factor in its spread is the role of asymptomatic carriers, who not only facilitate tr...

    Authors: Ahmed Azzam, Heba Khaled, Heba Mohamed Fayed, Youssef Mansour, Mariam Eldalil, Eslam Elshennawy, Haitham Salem and Hoda A. Elkatan
    Citation: BMC Infectious Diseases 2025 25:505
  10. Although many studies have examined the connection between mutations in the rpoB gene and drug resistance, the impact of common mutations on treatment outcomes for RR-TB is not yet fully understood.

    Authors: Maria Jose Vadakunnel, Vijayalakshmi Jawaharlal Nehru, Usharani Brammacharry, Venkateswari Ramachandra, Suganthi Palavesam, Anbazhagi Muthukumar, Balasundaram Revathi Mani, Sriramkumar S. R, Gunavathy Pradhabane, Azger Dusthackeer VN, Sangeetha Subramani, Muthuraj Muthaiah and Govindarajan Soundappan
    Citation: BMC Infectious Diseases 2025 25:284

Submission Guidelines

Back to top

This Collection welcomes submission of original Research Articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Infectious disease and antibiotic resistance epidemiology" from the dropdown menu.

All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.